Ignite Creation Date:
2025-12-17 @ 2:48 PM
Ignite Modification Date:
2025-12-23 @ 4:53 PM
Study NCT ID:
NCT02624895
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2015-11-09
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-09
First Submit QC Date:
None
Study First Post Date:
2015-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-20
Last Update Post Date:
2021-01-22
Last Update Post Date Type:
ACTUAL